Kadcyla and Von Willebrand factor recombinant

• Generic Name: ado-trastuzumab emtansine
• Dosage Forms: injection, powder, lyophilized, for solution
• Other Brand Names: Kadcyla

Kadcyla (ado-trastuzumab emtansine) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Kadcyla is used to treat HER2-positive breast cancer.

Kadcyla is used both for early breast cancer and for breast cancer that has spread to other parts of the body (metastatic).

Kadcyla is usually given after other cancer medications have been tried without success.

Kadcyla should not be used in place of Herceptin (trastuzumab).

• Generic Name: von willebrand factor
• Dosage Forms: n.a.
• Other Brand Names: Vonvendi, Wilfactin

Von Willebrand factor is a naturally occurring protein in the blood that helps blood to clot. People with an inherited blood-clotting disorder called von Willebrand disease do not have enough of this protein in their blood. A lack of von Willebrand factor can cause uncontrolled bleeding.

Von Willebrand factor is used to control bleeding episodes in adults with von Willebrand disease.

Von Willebrand factor may also be used for purposes not listed in this medication guide.